As families, patients, and healthcare workers, we all face difficult choices — ethical guidance helps us make them with ...

All-cause mortality risk was over six times higher for people with young-onset dementia versus controls. Median survival was ...

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention ...

The survival rates of people with early onset dementia—diagnosed before the age of 65—vary considerably by clinical type, but ...

Shares of Intellia Therapeutics (NTLA) crashed ~28% in the premarket on Friday after the company disclosed that a patient who ...

Clinical trial sites often open and close rapidly, with 60% ceasing operations within the first year, impacting patient ...

"The deceased was a much loved daughter, sister, and aunt, whose untimely death has caused deep and enduring grief to her ...

Advocates for prisoners say the recent deaths "raise fundamental questions about whether the DOC can fulfill its most basic ...

When the kidneys are damaged—after surgery, cardiac arrest, or as a side effect of certain medications—doctors often face one ...

Kygevi (doxecitine and doxribtimine) earned FDA approval as the first treatment for thymidine kinase 2 deficiency, supported by data from a Phase II trial and multiple retrospective studies showing ...

Cause-specific mortality patterns in paediatric cerebral malaria revealed multiple distinct immediate causes of death ...

Dr Jill Millar, a retired GP living with terminal cancer, argues that we need to stop using euphemisms and start talking ...